The Omics Center Graz bundles the expertise and existing infrastructure in genomics, transcriptomics, proteomics, and metabolomics/lipidomics, as well as bioinformatics and administration of research centers in Graz. The center builds upon successful scientific collaborations between three universities of Graz (Medical University of Graz, University of Graz and University of Technology of Graz) in the last years in large scale projects (GENAU GOLD, GENAU BIN, SFB Lipotox, DK-Molecular Enzymology, DK-MCD, EU Lipidomic Net, ACIB, RCPE etc.), and in the Lipidomic Research Center Graz, as referenced by numerous high ranking publications, and was officially launched on June 5th, 2014, as a BioTechMed initiative. Special emphasis is put on bioinformatics and measurement capacity, in order to perform more comprehensive omic studies and multi- omic projects. Such organized strategies will facilitate the obtainment of sustainable knowledge from the largest European Biobank which is located in Graz, as well as the implementation of biomarker research in Graz. From this initiative highly profit next to molecular biomedicine, particularly the strong lipid research network and research competence centers with close connection to industry (e.g. ACIB, RCPE), and young researchers finding training in state of the art high end technologies in Graz .
The Omics Center Graz is part of the BioTechMed initiative.